|
|
|
|
| LEADER |
01467nam a2200265 u 4500 |
| 001 |
EB002000625 |
| 003 |
EBX01000000000000001163526 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Brett, Kendra
|
| 245 |
0 |
0 |
|a Identification of tuberculosis
|h Elektronische Ressource
|b a review of the guidelines
|c Kendra Brett, Camille Dulong, Melissa Severn
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa
|b Canadian Agency for Drugs and Technologies in Health
|c 2020, February 6, 2020
|
| 300 |
|
|
|a 1 PDF file (54 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a Dulong, Camille
|e [author]
|
| 700 |
1 |
|
|a Severn, Melissa
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK562928
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this report is to review and critically appraise the evidence-based guidelines regarding interventions for the identification of TB. This report is part of series of evidence reviews on TB guidelines and can serve as a guidance document to identify which guidelines include recommendations for specific identification methods and specific populations of interest, and the strength of the guidelines
|